278 results on '"Smith, Coleman"'
Search Results
2. Revet: A Language and Compiler for Dataflow Threads
3. Outcomes of early vs late treatment initiation in solid organ transplantation from hepatitis C virus nucleic acid test-positive donors to hepatitis C virus-uninfected recipients: Results from the HCV-TARGET study
4. Validation of a Clinical Risk-based Classification System in a Large Nonalcoholic Fatty Liver Disease Real-world Cohort
5. Immunotherapy and Hepatocellular Carcinoma
6. Living kidney donors with HIV: experience and outcomes from a case series by the HOPE in Action Consortium
7. Factors Impacting Survival in Those Transplanted for NASH Cirrhosis: Data From the NailNASH Consortium
8. Safety and Effectiveness of Tenofovir Alafenamide in Usual Clinical Practice Confirms Results of Clinical Trials: TARGET-HBV
9. Revet: A Language and Compiler for Dataflow Threads
10. Adherence to clinical follow-up recommendations for liver function tests: A cross-sectional study of patients with HCV and their associated risk behaviors
11. Retrospective-prospective study of safety and efficacy of sofosbuvir-based direct-acting antivirals in HIV/HCV-coinfected participants with decompensated liver disease pre– or post–liver transplant
12. Maternal knowledge of the risk of vertical transmission and offspring acquisition of hepatitis B
13. Hepatitis B: Current Status of Therapy and Future Therapies
14. Characteristics of Adults in the Hepatitis B Research Network in North America Reflect Their Country of Origin and Hepatitis B Virus Genotype
15. Long-term survival in visceral transplant recipients in the new era: A single-center experience
16. Transcriptomics of MASLD Pathobiology in African American Patients in the Washington DC Area †
17. Validation of a Clinical Risk-based Classification System in a Large Nonalcoholic Fatty Liver Disease Real-world Cohort
18. Outcomes of early vs late treatment initiation in solid organ transplantation from hepatitis C virus nucleic acid test-positive donors to hepatitis C virus-uninfected recipients: Results from the HCV-TARGET study
19. Living kidney donors with HIV: experience and outcomes from a case series by the HOPE in Action Consortium
20. Outcomes of early vs late treatment initiation in solid organ transplantation from HCV NAT+ donors to HCV-uninfected recipients: results from the HCV-TARGET study
21. Characteristics of Adults in the Hepatitis B Research Network in North America Reflect Their Country of Origin and Hepatitis B Virus Genotype
22. Bridging and downstaging with TACE in early and intermediate stage hepatocellular carcinoma: Predictors of receiving a liver transplant
23. S2593 Hemorrhagic Shock From a Duodenal Ulcer Eroding Into an Ectopic Varix
24. Safety and Dosing Study of a Cholecystokinin Receptor Antagonist in Non‐alcoholic Steatohepatitis
25. Alcohol‐associated liver disease predicts increased post‐liver transplant opioid use
26. Hemorrhagic Shock from a Duodenal Ulcer Eroding into an Ectopic Varix.
27. Safety and yield of percutaneous liver biopsy in adults and children with chronic hepatitis B: Results from a prospective, multicenter study.
28. Prevalence of hepatitis B antiviral drug resistance variants in North American patients with chronic hepatitis B not receiving antiviral treatment
29. Bridging and downstaging with TACE in early and intermediate stage hepatocellular carcinoma: Predictors of receiving a liver transplant.
30. Tu1322: PHASE 1 STUDY TO TEST SAFETY AND DOSE OF A CHOLECYSTOKININ RECEPTOR ANTAGONIST, PROGLUMIDE, IN NON-ALCOHOLIC STEATOHEPATITIS (NASH)
31. Safety and Pharmacokinetic Assessment of Oral Proglumide in Those with Hepatic Impairment
32. Diet and Activity Programs Are Ineffective in Nonalcoholic Steatohepatitis
33. Risk factors for bleeding hepatocellular adenoma in a United States cohort
34. A Simplified Solid-State Transformer Model for Teaching Basic Concepts and Ideas
35. U.S. Multicenter Pilot Study of Daily Consensus Interferon (CIFN) Plus Ribavirin for “Difficult-to-Treat” HCV Genotype 1 Patients
36. Safety and Effectiveness of Tenofovir Alafenamide in Usual Clinical Practice Confirms Results of Clinical Trials: TARGET-HBV
37. Antiviral Response of HCV Genotype 1 to Consensus Interferon and Ribavirin Versus Pegylated Interferon and Ribavirin
38. OS-125 - Outcomes of early vs late treatment initiation in solid organ transplantation from HCV NAT+ donors to HCV-uninfected recipients: results from the HCV-TARGET study
39. Outcome of early and intermediate-stage hepatocellular carcinoma (HCC): A single institution experience at MGUH.
40. Immune checkpoint inhibitors in liver transplant recipients - a review of current literature
41. Safety and efficacy of sofosbuvir/velpatasvir/voxilaprevir in post-liver transplant patients with previous direct-acting antiviral failure: Six case reports
42. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection
43. NS5A: A new target for antiviral drugs in the treatment of hepatitis C virus infection
44. Hepatitis B
45. Predicting sustained virological responses in chronic hepatitis C patients treated with peginterferon alfa-2a (40 KD)/ribavirin
46. Risk factors for bleeding hepatocellular adenoma in a United States cohort.
47. Necrobiosis lipoidica
48. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease
49. The impact of peginterferon alfa-2a plus ribavirin combination therapy on health-related quality of life in chronic hepatitis C
50. Comparison of three doses of ursodeoxycholic acid in the treatment of primary biliary cirrhosis: a randomized trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.